(Q37741005)

22 August 2017

1 reference

title

Osteonecrosis of the jaws: clinicopathologic and radiologic characteristics, preventive and therapeutic strategies (English)

1 reference

22 August 2017

Vassilios Vassiliou

1

1 reference

22 August 2017

Nikolaos Tselis

series ordinal

2

1 reference

22 August 2017

Dimitrios Kardamakis

series ordinal

3

1 reference

22 August 2017

publication date

26 April 2010

1 reference

Strahlentherapie und Onkologie

22 August 2017

published in

1 reference

22 August 2017

volume

186

1 reference

22 August 2017

issue

7

1 reference

22 August 2017

page(s)

367-373

1 reference

https://scigraph.springernature.com/pub.10.1007/s00066-010-2066-9

22 August 2017

exact match

0 references

cites work

Combination ibandronate and radiotherapy for the treatment of bone metastases: clinical evaluation and radiologic assessment

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00066-010-2066-9

The management of metastatic bone disease with the combination of bisphosphonates and radiotherapy: from theory to clinical practice

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00066-010-2066-9

Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00066-010-2066-9

Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel

21 January 2018

1 reference

12 December 2020

Cytotoxicity analysis of alendronate on cultured endothelial cells and subcutaneous tissue. a pilot study.

1 reference

12 December 2020

Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases

1 reference

12 December 2020

Preclinical pharmacology of CGP 42'446, a new, potent, heterocyclic bisphosphonate compound

1 reference

12 December 2020

Bisphosphonates are incorporated into adenine nucleotides by human aminoacyl-tRNA synthetase enzymes

1 reference

12 December 2020

Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial--the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group

1 reference

12 December 2020

Nd:YAG laser biostimulation in the treatment of bisphosphonate-associated osteonecrosis of the jaw: clinical experience in 28 cases

1 reference

12 December 2020

Organ function and quality of life after transoral laser microsurgery and adjuvant radiotherapy for locally advanced laryngeal cancer

1 reference

12 December 2020

Inhibition of oral mucosal cell wound healing by bisphosphonates.

1 reference

12 December 2020

[Relevance of bisphosphonate long-term therapy in radiation therapy of endosteal jaw metastases]

1 reference

12 December 2020

Changes in bone histomorphometry after long-term treatment with intermittent, cyclic etidronate for postmenopausal osteoporosis

1 reference

12 December 2020

Oral ibandronate improves bone pain and preserves quality of life in patients with skeletal metastases due to breast cancer

1 reference

12 December 2020

Bisphosphonates: new therapeutic agents for the treatment of bone tumors

1 reference

12 December 2020

Development and management of severe cutaneous side effects in head-and-neck cancer patients during concurrent radiotherapy and cetuximab

1 reference

12 December 2020

Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer.

1 reference

12 December 2020

Bisphosphonates and osteonecrosis of the jaws: science and rationale

1 reference

12 December 2020

Long-term safety of bisphosphonates

1 reference

12 December 2020

Bisphosphonates and bone metastases: current status and future directions

1 reference

12 December 2020

Development of bisphosphonates

1 reference

12 December 2020

Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates.

1 reference

12 December 2020

Hyperbaric oxygen treatment and bisphosphonate-induced osteonecrosis of the jaw: a case series

1 reference

12 December 2020

Phase I trial of radiochemotherapy with bendamustine in patients with recurrent squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer

1 reference

12 December 2020

Treatment of avascular osteonecrosis of the mandible in cancer patients with a history of bisphosphonate therapy by combining bone resection and autologous platelet-rich plasma: Report of 3 cases

1 reference

12 December 2020

Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?

1 reference

12 December 2020

The potential of farnesyltransferase inhibitors as cancer chemotherapeutics

1 reference

12 December 2020

[Retardation of progression of bone metastasis in mammary carcinoma patients by intravenous pamidronate treatment: results of a randomized, controlled, multinational study]

1 reference

12 December 2020

Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors

1 reference

12 December 2020

Osteoradionecrosis of the mandibula in patients treated with different fractionations.

1 reference

12 December 2020

Osteonecrosis of the jaw related to the use of bisphosphonates.

1 reference

12 December 2020

Managing metastatic bone pain: the role of bisphosphonates

1 reference

12 December 2020

[The efficacy of pamidronate in reducing skeletal associated events in patients with advanced multiple myeloma]

1 reference

12 December 2020

Bisphosphonates and radiation therapy for palliation of metastatic bone disease

1 reference

12 December 2020

Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies

1 reference

12 December 2020

The role of bisphosphonates in breast and prostate cancers

1 reference

12 December 2020

The treatment of bisphosphonate-associated osteonecrosis of the jaws with bone resection and autologous platelet-derived growth factors

1 reference

12 December 2020

Osteonecrosis of the jaw in a patient treated with ibandronate

1 reference

12 December 2020

Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws.

1 reference

12 December 2020

Effects of radiotherapy for brain metastases on quality of life (QoL). Prospective pilot study of the DEGRO QoL working party

1 reference

12 December 2020

Critical review: updated recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in cancer patients--May 2006.

1 reference

12 December 2020

Osteoradionecrosis of the mandible: minimized risk profile following intensity-modulated radiation therapy (IMRT).

1 reference

12 December 2020

Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer

1 reference

12 December 2020

Effectiveness of bisphosphonates on bone pain and quality of life in breast cancer patients with metastatic bone disease: a review

1 reference

12 December 2020

Osteonecrosis of the jaws: a complication of cancer chemotherapy

1 reference

12 December 2020

A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid

1 reference

12 December 2020

Bisphosphonate-associated osteonecrosis of the auditory canal

1 reference

12 December 2020

Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment

1 reference

12 December 2020

Pain and quality of life following palliative radiotherapy of bone metastases

1 reference

12 December 2020

Bisphosphonates: clinical experience

1 reference

12 December 2020

Cellular and molecular mechanisms of action of bisphosphonates

1 reference

12 December 2020

Bisphosphonate complications including osteonecrosis of the jaw.

1 reference

12 December 2020

Comparison of the distribution of 3H-alendronate and 3H-etidronate in rat and mouse bones

1 reference

12 December 2020

Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure

1 reference

12 December 2020

10.1007/S00066-010-2066-9

Identifiers

DOI

1 reference

22 August 2017

1 reference